Stem Cell Assay Market Report 2026

Stem Cell Assay Market Overview

• Stem Cell Assay market size has reached to $2.84 billion in 2025 • Expected to grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 22.1% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Expansion Of The Stem Cell Assay Market • Market Trend: Innovative Product For Stem Cell Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stem Cell Assay Market?

Stem cells refer to cells which have the rare capacity to renew themselves and develop into specialized cell types. They act like the building blocks of all living things. Stem cell assay is developed for studying human stem cell growth to analyze the biological activities of stem cells in a controlled environment. The main types of stem cell assays market are cell viability and toxicity assays, cell apoptosis assays, cell function assays, cell identification assays, isolation and purification assays, cell differentiation assays, and others. Cell viability and cell toxicity assays are used to assess the physical and physiological well-being of cells in response to extracellular stimuli, chemical agents, medicinal treatments, or other situations, as well as when deciding on the best conditions for cell culture growth. The different products include instruments and detection kit that are used in several applications such as regenerative medicine and therapy development, drug discovery and development, and clinical research. The various end users are government research institutes, private research institutes, industry research.

What Is The Stem Cell Assay Market Growth Forecast?

The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to cell-based therapy development, assay standardization demand, pharmaceutical screening applications, ai-enabled assay analysis, emerging biotech startups. Major trends in the forecast period include high-throughput assay platforms, functional stem cell analysis, integration with omics technologies, automated cell viability testing, standardized assay kits.

Global Stem Cell Assay Market Segmentation

1) By Assay Type: Cell Viability And Toxicity Assays, Cell Apoptosis Assays, Cell Function Assays, Cell Identification Assays, Isolation And Purification Assays, Cell Differentiation Assay, Other Types 2) By Product: Instruments, Detection kit 3) By Application: Regenerative Medicine And Therapy Development, Drug Discovery And Development, Clinical Research 4) By End User: Government Research Institutes, Private Research Institutes, Industry Research Subsegments: 1) By Cell Viability and Toxicity Assays: MTT Assay, Resazurin Assay, ATP Assay, LDH Release Assay 2) By Cell Apoptosis Assays: Caspase Activity Assays, Annexin V Staining Assays, TUNEL Assay, Cell Death Detection Assays 3) By Cell Function Assays: Proliferation Assays, Migration And Invasion Assays, Differentiation Assays 4) By Cell Identification Assays: Flow Cytometry-Based Assays, Surface Marker Characterization, Immunocytochemistry Assays 5) By Isolation and Purification Assays: Magnetic-Activated Cell Sorting (MACS), Fluorescence-Activated Cell Sorting (FACS), Density Gradient Centrifugation 6) By Cell Differentiation Assay: Lineage-Specific Differentiation Assays, Gene Expression Analysis During Differentiation 7) By Other Types: 3D Culture Assays, High-Content Screening Assays, Biomarker Discovery Assays

What Is The Driver Of The Stem Cell Assay Market?

The high prevalence of chronic diseases is expected to propel the growth of the stem cell assay market going forward. Chronic disease refers to an ailment or illness that often lasts for three months or longer and has the potential to worsen over time. Stem cells have the potential to treat a wide range of diseases, including chronic diseases. They help in the development of new antibodies and specialized cells that help to cure chronic diseases such as cancer. For instance in March 2024, according to The Government of the United Kingdom, a UK-based website, In the financial year ending in 2023, slightly more than 1,862,500 people in England, representing 3% of the population, had a GP diagnosis of coronary heart disease (CHD). Therefore, the increase in the prevalence of chronic diseases is driving the growth of the stem cell assay industry.

Key Players In The Global Stem Cell Assay Market

Major companies operating in the stem cell assay market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.

Global Stem Cell Assay Market Trends and Insights

Major companies operating in the stem cell assay market are focusing on developing technological advancements such as next-generation tissue dissociation and sample preparation systems to enhance cell viability, processing efficiency, and reproducibility across research applications. Advanced dissociation platforms enable automated, gentle, and standardized processing of complex tissues, supporting high-quality single-cell suspensions essential for downstream stem cell research, regenerative medicine, and cell-based assays. For instance, in June 2025, STEMCELL Technologies, a Canada-based biotechnology company specializing in tools for stem cell research, introduced the STEMprep Tissue Dissociator System, an integrated mechanical and enzymatic dissociation platform designed to simplify and accelerate tissue processing workflows. The system delivers programmable protocols, closed-system handling, and consistent cell yields, empowering researchers to reduce processing time, minimize variability, and improve assay reliability while advancing discoveries in stem cell biology and translational research.

What Are Latest Mergers And Acquisitions In The Stem Cell Assay Market?

In June 2025, STEMCELL Technologies, a Canada-based provider of specialty cell culture media, reagents, and tools for cell biology research, acquired Cellular Highways Ltd for an undisclosed amount. With this acquisition, STEMCELL Technologies aims to strengthen its cell processing and cell therapy manufacturing capabilities by integrating advanced microfluidics-based cell sorting platforms, accelerating innovation in scalable, high-throughput research workflows, and expanding its portfolio of tools supporting translational and clinical applications. Cellular Highways Ltd is a UK-based biotechnology company specializing in high-speed microfluidic cell sorting technologies designed to enhance cell separation accuracy and processing efficiency.

Regional Outlook

North America was the largest region in the stem cell assay market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell Assay Market?

The stem cell assay market consists of sales of tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, proliferation assays, differentiation assays, function assays, caspase assays and annexin v and cell permeability assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stem Cell Assay Market Report 2026?

The stem cell assay market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell assay industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.